AUTOLUS THERAPEUTICS PLC ADS overview
AUTOLUS THERAPEUTICS PLC ADS
> News
GlobeNewsWire published a news.
Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL)
•
•
GlobeNewsWire •
Stocks •
More AUTOLUS THERAPEUTICS PLC ADS news...
Thank you
Chart
Statistics
- Analyses : 2
- Followers : 0